Advertisement

Tumor Infiltrating Lymphocytes (TIL) and Neoadjuvant Chemotherapy in Esophageal Cancer

  • Toshitada Okuma
  • Yoshitsugu Torigoe
  • Keiichiro Kondo
  • Kenji Okamura
  • Yoshimasa Miyauchi
Conference paper

Abstract

Cisplatin (CDDP) has an antineoplastic action mechanism which directly inhibits DNA synthesis. However, another action mechanism of cytotoxic action, i.e., enhancement of spontaneous monocyte-mediated cytotoxicity (SMMC) has been reported [1].

Keywords

Esophageal Cancer Adoptive Immunotherapy Medial Grade Preoperative Therapy High Grade Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kleinerman ES, Zwelling LA, Muchmore AV (1980) Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum ( II ). Cancer Res 40: 3099–3102PubMedGoogle Scholar
  2. 2.
    Japanese Society for Esophageal Diseases: Guidelines for the clinical and pathologic studies on carcinoma of the esophagus ( 8th edition ), Tokyo, Kanehara (1992)Google Scholar
  3. 3.
    Shimozato Y, Oboshi S, Baba K (1971) Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1: 19–35Google Scholar
  4. 4.
    Presnov MA, Konoalova AL, Romanova LF, et al (1978) Chemotherapy of transplantable mouse tumors with cis-dichloro-diamminplatinum ( II) alone and in combination with sarcolysin. Cancer Treat Rep 62: 705–712PubMedGoogle Scholar
  5. 5.
    Svet-Moldavsky GJ, Hamburg VP (1964) Quantitative relationships in viral oncolysis and the possibility of artificial heterogenization of tumors. Nature 202: 303–304PubMedCrossRefGoogle Scholar
  6. 6.
    Tahara H, Shiozaki H, Kobayashi K, Yano H, Tamura S, Miyata M, Wakasa K, Sakurai M, Mori T (1990) Principal lymphocyte subpopulation in local host response to human oesophageal cancer. Virchows Arch [A] 417: 311–317CrossRefGoogle Scholar
  7. 7.
    Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318–1321PubMedCrossRefGoogle Scholar
  8. 8.
    Kradin RL, Boyle LA, Preffer FI, Callahan RJ, Barlai-Kovach M, Strauss HW, Dubinett S, Kurnick JT (1987) Tumor-derived interleukin-2 dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol Immunother 24: 76–85PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1993

Authors and Affiliations

  • Toshitada Okuma
  • Yoshitsugu Torigoe
  • Keiichiro Kondo
  • Kenji Okamura
  • Yoshimasa Miyauchi
    • 1
  1. 1.First Department of SurgeryKumamoto University School of MedicineKumamoto City, Kumamoto, 860Japan

Personalised recommendations